Background: Pulmonary hypertension (PH) is a well-known independent prognostic factor in chronic obstructive pulmonary disease (COPD) and a sufficient criterion for lung transplant candidacy. Limited data are currently available on the hemodynamic and clinical effect of phosphodiesterase 5 inhibitors in patients with severe PH associated with COPD. This study assessed the effect of sildenafil on pulmonary hemodynamics and gas exchange in severe PH associated with COPD. Methods: After screening, this multicenter, randomized, placebo-controlled double-blind trial randomized patients to receive 20 mg sildenafil or placebo 3 times a day (ratio 2:1) for 16 weeks. The primary end point was the reduction in pulmonary vascular resistance. Secondary end points included BODE (body mass index, airflow obstruction, dyspnea, and exercise capacity) index, 6-minute walk test, and quality of life questionnaire. Changes in the partial pressure of arterial oxygen were evaluated as a safety parameter. Results: The final population included 28 patients, 18 in the sildenafil group and 10 in the placebo group. At 16 week, patients treated with sildenafil had a decrease in pulmonary vascular resistance (mean difference with placebo -1.4 WU; 95% confidence interval, ≤ -0.05; p = 0.04). Sildenafil also improved the BODE index, diffusion capacity of the lung for carbon monoxide percentage, and quality of life. Change from baseline in the partial pressure of arterial oxygen was not significantly different between the sildenafil and placebo groups. Conclusions: This pilot study found that treatment with sildenafil reduced pulmonary vascular resistance and improved the BODE index and quality of life, without a significant effect on gas exchange.

Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease. a randomized controlled multicenter clinical trial / Vitulo, Patrizio; Stanziola, Anna; Confalonieri, Marco; Libertucci, Daniela; Oggionni, Tiberio; Rottoli, Paola; Paciocco, Giuseppe; Tuzzolino, Fabio; Martino, Lavinia; Beretta, Marta; Callari, Adriana; Amaducci, Andrea; Badagliacca, Roberto; Poscia, Roberto; Meloni, Federica; Refini, Rosa Metella; Geri, Pietro; Baldi, Sergio; Ghio, Stefano; D'Alto, Michele; Argiento, Paola; Sofia, Matteo; Guardamagna, Mara; Pizzuto, Beatrice; Vizza, Carmine Dario. - In: THE JOURNAL OF HEART AND LUNG TRANSPLANTATION. - ISSN 1053-2498. - ELETTRONICO. - 36:2(2016), pp. 166-174. [10.1016/j.healun.2016.04.010]

Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease. a randomized controlled multicenter clinical trial

BADAGLIACCA, ROBERTO;POSCIA, ROBERTO;VIZZA, Carmine Dario
2016

Abstract

Background: Pulmonary hypertension (PH) is a well-known independent prognostic factor in chronic obstructive pulmonary disease (COPD) and a sufficient criterion for lung transplant candidacy. Limited data are currently available on the hemodynamic and clinical effect of phosphodiesterase 5 inhibitors in patients with severe PH associated with COPD. This study assessed the effect of sildenafil on pulmonary hemodynamics and gas exchange in severe PH associated with COPD. Methods: After screening, this multicenter, randomized, placebo-controlled double-blind trial randomized patients to receive 20 mg sildenafil or placebo 3 times a day (ratio 2:1) for 16 weeks. The primary end point was the reduction in pulmonary vascular resistance. Secondary end points included BODE (body mass index, airflow obstruction, dyspnea, and exercise capacity) index, 6-minute walk test, and quality of life questionnaire. Changes in the partial pressure of arterial oxygen were evaluated as a safety parameter. Results: The final population included 28 patients, 18 in the sildenafil group and 10 in the placebo group. At 16 week, patients treated with sildenafil had a decrease in pulmonary vascular resistance (mean difference with placebo -1.4 WU; 95% confidence interval, ≤ -0.05; p = 0.04). Sildenafil also improved the BODE index, diffusion capacity of the lung for carbon monoxide percentage, and quality of life. Change from baseline in the partial pressure of arterial oxygen was not significantly different between the sildenafil and placebo groups. Conclusions: This pilot study found that treatment with sildenafil reduced pulmonary vascular resistance and improved the BODE index and quality of life, without a significant effect on gas exchange.
2016
BODE index; chronic obstructive pulmonary disease; end-stage lung disease; lung transplantation; pulmonary hypertension; sildenafil; surgery; pulmonary and respiratory medicine; cardiology and cardiovascular medicine; transplantation
01 Pubblicazione su rivista::01a Articolo in rivista
Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease. a randomized controlled multicenter clinical trial / Vitulo, Patrizio; Stanziola, Anna; Confalonieri, Marco; Libertucci, Daniela; Oggionni, Tiberio; Rottoli, Paola; Paciocco, Giuseppe; Tuzzolino, Fabio; Martino, Lavinia; Beretta, Marta; Callari, Adriana; Amaducci, Andrea; Badagliacca, Roberto; Poscia, Roberto; Meloni, Federica; Refini, Rosa Metella; Geri, Pietro; Baldi, Sergio; Ghio, Stefano; D'Alto, Michele; Argiento, Paola; Sofia, Matteo; Guardamagna, Mara; Pizzuto, Beatrice; Vizza, Carmine Dario. - In: THE JOURNAL OF HEART AND LUNG TRANSPLANTATION. - ISSN 1053-2498. - ELETTRONICO. - 36:2(2016), pp. 166-174. [10.1016/j.healun.2016.04.010]
File allegati a questo prodotto
File Dimensione Formato  
Vitulo_Sildenafil_2016.pdf

solo gestori archivio

Note: articolo principale
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 711.51 kB
Formato Adobe PDF
711.51 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/901474
Citazioni
  • ???jsp.display-item.citation.pmc??? 28
  • Scopus 80
  • ???jsp.display-item.citation.isi??? 72
social impact